Ad from Google

Twitter Updates

    follow me on Twitter

    My Profile

    • EXPERTISE -
      Authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; issues and crisis management. Frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!

    About This Blog

    • Eye on FDA is published by Mark Senak of Fleishman-Hillard's Washington, D.C. office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of Fleishman-Hillard or its clients.

    My Favorite Dogs

    • January20063_005
      Nick and Nora

    Stats

    • eXTReMe Tracker

    Eye on FDA edrugsearch blog ranking

    • Healthcare 100

    Syndication

    « Google Provides a Virtual Focus Group of Sorts | Main | Weekly Roundup - 10/10/08 »

    October 09, 2008

    Warning Letter Summary - Third Quarter 2008, Part 1

    J0386036Even the most casual observer will have noticed that across the board, under the Bush Administration, there has been a drastic curtailment by domestic agencies in the enforcement of regulations.  Critics and policymakers have assailed the track records of several agencies.  The Federal Election Commission lacked membership.  The Environmental Protection Agency has been cited for not acting to protect clean air, to name a few.  The Food and Drug Administration has been no different, as I've noted here many times.  The Division of Drug Marketing and Advertising (DDMAC) at the Center for Drug Evaluation and Research (CDER) track record demonstrates how enforcement has declined, despite the fact that PDUFA dollars have gone up:

    YEAR                # OF DDMAC WARNING LETTERS

    2008                                               13  (first 3 quarters only)

    2007                                               20   

    2006                                               22

    2005                                               29

    2004                                               23

    2003                                               25

    2002                                               28

    2001                                                64

    2000                                               75

    1999                                              108

    1998                                              156

    1997                                              139

    But what is extraordinary about 2008 is that, despite the fact that there have only been 13 letters issued by DDMAC this year, a whopping six, count 'em SIX letters were issued in one week and FIVE of them were in a single day.  What's that about?

    Part 2 of this posting will come either later today or tomorrow, and will examine any commonalities among the letters that might indicate a new pattern by FDA.  Or, what we may be seeing is that as the sun sets on this Administration, non-political appointee employees are ramping up enforcement again, so that these agencies may once again be fulfilling their mission to a degree not seen for the past 8 years.  That might signal a slew of such letters to come in the coming weeks, and most certainly, I would think, in the next Administration.

    TrackBack

    TrackBack URL for this entry:
    http://www.typepad.com/services/trackback/6a00d83451bf5969e2010535762210970c

    Listed below are links to weblogs that reference Warning Letter Summary - Third Quarter 2008, Part 1:

    Comments

    I realize that the actual number of letters titled "warning letters" vs. untiltled letters has gone down over the years. I was under the impression that several years ago, DDMAC changed how they issue these letters in that they no require legal review prior to issuing communications to Pharma concerning promotion violations. Can you identify the number of untitled letters this group has sent out regarding same? I would believe that not all violations first come as a "warning letter".

    Verify your Comment

    Previewing your Comment

    This is only a preview. Your comment has not yet been posted.

    Working...
    Your comment could not be posted. Error type:
    Your comment has been posted. Post another comment

    The letters and numbers you entered did not match the image. Please try again.

    As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

    Having trouble reading this image? View an alternate.

    Working...

    Post a comment

    Ad from Google

    Subscribe / Email Me

    Enter your email address:

    Delivered by FeedBurner

    Search

    • Google

      WWW
      eyeonfda.com

    July 2009

    Sun Mon Tue Wed Thu Fri Sat
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30 31